Health-Care System Is Fundamentally Broken: 23andMe CEO

The transcript discusses the challenges in the healthcare system, emphasizing the need for consumer-centric approaches. It highlights 23andMe's journey, including FDA regulations and the shift towards being a medical device company. The importance of understanding regulatory landscapes and engaging healthcare experts is stressed. The potential for consumer-driven transformation in healthcare, through collaboration and innovation, is explored. The transcript also covers the role of genetic data in personalized care and the necessity of partnerships with regulators to advance healthcare research and innovation.

What is the core issue identified in the healthcare system according to the speaker?

What challenges did 23andMe face regarding FDA regulations?

How has 23andMe changed its approach to consumer genetic information over time?

What role do healthcare executives play in the evolution of 23andMe's business?

In what ways does the speaker envision transforming healthcare through consumer involvement?

What is the significance of the roundtable held by Jill Hacking for 23andMe?

How does the speaker describe the relationship between genetic information and personalized care?